May 3, 2025
by Dominik Tomicevic
Biopharma insight
An estimated 6.9 million Americans aged 65 and older are living with Alzheimer’s. Without major medical breakthroughs, that number is …
April 30, 2025
by Roman Kasianov
News
A global team of researchers has carried out what may be the most ambitious attempt yet to test two of …
April 30, 2025
by Roman Kasianov
News
Nurix Therapeutics presented new data at the 2025 AACR Annual Meeting supporting the capabilities of its DEL-AI platform—a machine learning–powered …
Eli Lilly has signed a strategic partnership with Creyon Bio to develop AI-designed oligonucleotide therapeutics, committing $13 million upfront and up …
April 30, 2025
by Roman Kasianov
News
The National Institutes of Health (NIH) has launched a new initiative to expand the use of human-based research technologies while …
April 29, 2025
by Roman Kasianov
News
San Francisco-based startup founded by Brandon White and Alex Beatson has announced $15 million in seed funding from Amplify Partners, …
Raidium, a Paris-based medical AI company founded in 2022 by radiologist Dr. Paul Hérent and data scientist Pierre Manceron, focuses …
April 28, 2025
by Roman Kasianov
News
Tempus AI, Inc. (NASDAQ: TEM) announced the launch of Tempus Loop, a proprietary oncology-focused platform designed to streamline target discovery …
April 24, 2025
by Roman Kasianov
News
Paige and NHS Wales have launched a pilot project at Betsi Cadwaladr University Health Board (BCUHB) to evaluate the clinical …
April 24, 2025
by BiopharmaTrend
Biopharma insight
Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying …
Immunai and the Parker Institute for Cancer Immunotherapy (PICI) have announced a collaboration to build what they describe as the …
April 23, 2025
by Roman Kasianov
News
Seattle-based startup Potato has raised $4.5 million in seed funding to accelerate development of its AI platform for automating scientific …